NO20000151L - Nitrogenoksid inhiberer rhinovirus infeksjon - Google Patents

Nitrogenoksid inhiberer rhinovirus infeksjon

Info

Publication number
NO20000151L
NO20000151L NO20000151A NO20000151A NO20000151L NO 20000151 L NO20000151 L NO 20000151L NO 20000151 A NO20000151 A NO 20000151A NO 20000151 A NO20000151 A NO 20000151A NO 20000151 L NO20000151 L NO 20000151L
Authority
NO
Norway
Prior art keywords
nitric oxide
rhinovirus infection
oxide inhibits
inhibits rhinovirus
inhibit
Prior art date
Application number
NO20000151A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000151D0 (no
Inventor
Scherer P Sanders
David Proud
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of NO20000151D0 publication Critical patent/NO20000151D0/no
Publication of NO20000151L publication Critical patent/NO20000151L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20000151A 1997-07-11 2000-01-11 Nitrogenoksid inhiberer rhinovirus infeksjon NO20000151L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5230797P 1997-07-11 1997-07-11
PCT/US1998/014466 WO1999002148A1 (en) 1997-07-11 1998-07-10 Nitric oxide inhibits rhinovirus infection

Publications (2)

Publication Number Publication Date
NO20000151D0 NO20000151D0 (no) 2000-01-11
NO20000151L true NO20000151L (no) 2000-03-09

Family

ID=21976738

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000151A NO20000151L (no) 1997-07-11 2000-01-11 Nitrogenoksid inhiberer rhinovirus infeksjon

Country Status (14)

Country Link
US (1) US6277891B1 (pt)
EP (1) EP1011657A1 (pt)
JP (1) JP2001509481A (pt)
KR (1) KR20010021749A (pt)
CN (1) CN1277552A (pt)
AU (1) AU8399098A (pt)
BR (1) BR9811473A (pt)
CA (1) CA2303430A1 (pt)
CZ (1) CZ200092A3 (pt)
HU (1) HUP0002859A2 (pt)
ID (1) ID23780A (pt)
NO (1) NO20000151L (pt)
TR (1) TR200000157T2 (pt)
WO (1) WO1999002148A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030753A1 (es) * 2000-09-25 2003-09-03 Smithkline Beecham Corp Uso de moduladores-proteina de il-8, groalfa, grobeta, grogamma, nap-2, y ena-78, para tratar infecciones viricas
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
DE10303196A1 (de) * 2003-01-28 2004-08-12 Märtz, Hans Helmut Verwendung von Erzeugnissen, Stoffen oder Stoffgemischen, aus welchen im menschlichen oder tierischen Körper Stickoxid (Formel: NO) entsteht, zur Behandlung oder Prophylaxe von Infektionskrankheiten des menschlichen oder tierischen Körpers
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
AU2004257693B8 (en) 2003-07-09 2009-08-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
US8252591B2 (en) 2004-05-07 2012-08-28 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US8557300B2 (en) * 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
GB0607402D0 (en) * 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
WO2009023194A2 (en) 2007-08-10 2009-02-19 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
US20090196930A1 (en) * 2007-12-27 2009-08-06 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
US8895282B2 (en) * 2008-03-20 2014-11-25 Tanomed Ab Use of a substance for manufacturing of a medicament for treatment of common cold
US11850283B2 (en) * 2017-06-27 2023-12-26 Ohio State Innovation Foundation Liponucleotide-based therapy for asthma
CN109432122A (zh) * 2018-11-19 2019-03-08 罗辉 No或no供体在制备预防和/或治疗皮肤疾病或黏膜疾病药物中的应用及药物组合物
CN109846113A (zh) * 2018-11-29 2019-06-07 南京诺全生物医疗科技有限公司 一种可自提供一氧化氮的口鼻卫生用品

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455279A (en) 1991-04-19 1995-10-03 The Children's Medical Center Corporation Regimen method of mediating neuronal damage using nitroglycerine

Also Published As

Publication number Publication date
US6277891B1 (en) 2001-08-21
WO1999002148A1 (en) 1999-01-21
ID23780A (id) 2000-05-11
JP2001509481A (ja) 2001-07-24
HUP0002859A2 (hu) 2001-01-29
NO20000151D0 (no) 2000-01-11
CZ200092A3 (en) 2001-05-16
CN1277552A (zh) 2000-12-20
CA2303430A1 (en) 1999-01-21
EP1011657A1 (en) 2000-06-28
AU8399098A (en) 1999-02-08
KR20010021749A (ko) 2001-03-15
TR200000157T2 (tr) 2001-06-21
BR9811473A (pt) 2001-12-26

Similar Documents

Publication Publication Date Title
NO20000151L (no) Nitrogenoksid inhiberer rhinovirus infeksjon
DK66493D0 (da) Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
EA200300810A1 (ru) Вирус, вызывающий заболевание дыхательных путей у восприимчивых млекопитающих
MY141594A (en) 3&#39;-PRODRUGS OF 2&#39;-DEOXY-ß-L-NUCLEOSIDES
NO985821L (no) Substituerte syklopentanforbindelser som er nyttige som neuraminidaseinhibitorer
DE69430232D1 (de) Hemmung der Symptome des prämenstruellen Synchroms/dysphorische Erkrankungen der späten lutealen Phase
MEP35308A (en) COMPOUNDS SPECIFIC TO ADENOSINE A1, A2a, AND A3 RECEPTOR AND USES THEREOF
ES2165269A1 (es) Derivados de alfa-cetoamidas.
ES2123156T3 (es) Compuestos y procedimientos de inhibicion de hiv y virus semejantes.
DK1089744T3 (da) Neurobeskyttende præparat til forebyggelse og/eller behandling af nervøse og adfærdsmæssige ændringer på grund af angsttilstande eller depression omfattende acetyl-L-carnitin og hypericin
CO5200855A1 (es) Uso de csaids en infecciones por rinovirus
ATE451934T1 (de) Pharmazeutische zusammensetzung zur behandlung von rhinitiden
DE60036862D1 (de) Synergistische hemmung von viralreplikation durch langkettigen kohlenwasserstoffe und nucleosid-analoge
AU2002249261A1 (en) Use of mek inhibitors for treating inflammation and virus induced hemorrhagic shock
SE0004101D0 (sv) New use
TR200200246T2 (tr) Nezle ve grip benzeri hastalıklar ile ilişkilendirilen semptomlardan korunma ve bunların tedavisi ile ilgili bileşim.
AP2001002181A0 (en) Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis C virus and other toga viruses.
NO981865L (no) FremgangsmÕter for konservering av mikroorganismer
WO2002026249A3 (en) Methods for inhibition of viral infection
DE3853672D1 (de) Nichtzurückschlagende RNS-Viren.
PT859613E (pt) Utilizacao de flupirtina para a profilaxia e o tratamento de doencas associadas a uma alteracao do sistema celular hematopoietico
BR9913598A (pt) Inibidores de protease de hiv
DK0576506T3 (da) Anvendelse af benzimidazol-anthelmintikum ved behandling af mikrosporidial-infektioner
PT1091933E (pt) Beta-dicetonas e sua utilizacao
ATE112489T1 (de) Extrakte von acanthospermum hispidum-pflanzen.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application